Hepatocyte nuclear factor-1α modulates pancreatic β-cell growth by regulating the expression of insulin-like growth factor-1 in INS-1 cells

Diabetes

Volumn 51, Issue 6, 2002, Pages 1785-1792

  Yang, Qin ^b   Yamagata, Kazuya ^b,e   Fukui, Kenji ^b   Cao, Yang ^b   Nammo, Takao ^b   Iwahashi, Hiromi ^b   Wang, Haiyan ^a,b   Matsumura, Itaru ^b   Hanafusa, Toshiaki ^b,c   Bucala, Richard ^b,d   Wollheim, Claes B ^a,b   Miyagawa, Jun Ichiro ^b   Matsuzawa, Yuji ^b  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b OSAKA UNIVERSITY   (Japan)

^c OSAKA MEDICAL COLLEGE   (Japan)

^d PICOWER INST FOR MEDICAL RESEARCH   (United States)

^e OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN E; GASTRIN; GLUCOSE; INSULIN; MACROPHAGE MIGRATION INHIBITION FACTOR; NUCLEAR FACTOR I; SOMATOMEDIN C;

ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE OVEREXPRESSION; GROWTH INHIBITION; HETEROZYGOSITY; HUMAN; HUMAN CELL; INSULIN RELEASE; KNOCKOUT MOUSE; MATURITY ONSET DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REGULATORY MECHANISM;

EID: 0036263625     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.6.1785     Document Type: Article

References (37)

1. Maturity-onset diabetes of the young: Clinical heterogeneity explained by genetic heterogeneity
2. Mutations in the human genes encoding the transcription factors of the hepatocyte nuclear factor (HNF)1 and HNF4 families: Functional and pathological consequences
3. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young
4. Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3)
5. Mutation P291fsinsC in the transcription factor hepatocyte nuclear factor-1α is dominant negative
6. Molecular targets of a human HNF1 alpha mutation responsible for pancreatic beta-cell dysfunction
7. Overexpression of dominant-negative mutant HNF-1α in pancreatic β-cells causes abnormal islet architecture with decreased expression of E-cadherin, reduced β-cell proliferation and diabetes
8. β-cell-targeted expression of a dominant-negative hepatocyte nuclear factor-1α induces a maturity-onset diabetes of the young (MODY)3-like phenotype in transgenic mice
9. Defective insulin secretion in hepatocyte nuclear factor 1α-deficient mice
10. Compensatory growth of pancreatic β-cells in adult rats after short-term glucose infusion
11. Insulin-like growth factor 1 (IGF-I)-stimulated pancreatic β-cell growth is glucose-dependent: Synergistic activation of insulin receptor substrate-mediated signal transduction pathways by glucose and IGF-I in INS-1 cells
12. Targeted expression of placental lactogen in the beta cells of transgenic mice results in beta cell proliferation, islet mass augmentation, and hypoglycemia
13. Pancreatic gastrin stimulates islet differentiation of transforming growth factor α-induced ductular precursor cells
14. Hepatocyte growth factor overexpression in the islet of transgenic mice increases beta cell proliferation, enhances islet mass, and induces mild hypoglycemia
15. Growth hormone is a growth factor for the differentiated pancreatic β-cell
16. Cytokine-induced apoptotic cell death in a mouse pancreatic beta-cell line: Inhibition by Bcl-2
17. Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF): Regulatory role in cell proliferation and glucocorticoid action
18. Insulin secretion is regulated by the glucose-dependent production of islet beta cell macrophage migration inhibitory factor
19. Cell cycle control of pancreatic beta cell proliferation
20. Growth hormone- and prolactin-induced proliferation of insulinoma cells, INS-1, depends on activation of STAT5 (signal transducer and activator of transcription 5)
21. Transgenic mice overexpressing insulin-like growth factor-II in β cells develop type 2 diabetes
22. Leukemia inhibitory factor induces neurotransmitter switching in transgenic mice
23. The promoter of the salmon insulin-like growth factor I gene is activated by hepatocyte nuclear factor 1
24. HNF1 activates transcription of the human gene for insulin-like growth factor binding protein-1
25. Cellular actions of insulin-like growth factor binding proteins
26. Selective translational control and nonspecific posttranscriptional regulation of ribosomal protein gene expression during development and regeneration of rat liver
27. Ribosomal proteins in cell proliferation and apoptosis
28. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation
29. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1
30. Dominant-negative suppression of HNF-1α results in mitochondrial dysfunction, INS-1 cell apoptosis, and increased sensitivity to ceramide-, but not to high glucose-induced cell death
31. Insulin-like growth factor I in the pancreas of normal and diabetic adult rats
32. Cellular distribution and ontogeny of insulin-like growth factors (IGFs) and IGF binding protein messenger RNAs and peptides in developing rat pancreas
33. Laron dwarfism and non-insulin dependent diabetes mellitus in the hnf-1α knock out mouse
34. Irs-2 coordinates Igf-1 receptor-mediated beta-cell development and peripheral insulin signalling
35. Insulin-like growth factor-I extends in vitro replicative life span of skeletal muscle satellite cells by enhancing G1/S cell cycle progression via the activation of phosphatidylinositol 3′-kinase/Akt signaling pathway
36. Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27(KIP1)
37. Beta-cell genes and diabetes: Quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1α and glucokinase mutations